Abstract | BACKGROUND & AIMS:
C/EBPbeta is an important mediator of several cellular processes, such as differentiation, proliferation, and survival of hepatic cells. However, a complete catalog of the targets of C/EBPbeta or the mechanism by which this transcription factor regulates certain liver-dependent pathways has not been clearly determined. Two major natural isoforms of this transcription factor exist: the liver-enriched activating protein (LAP) and the liver-enriched inhibitory protein (LIP), a functional LAP antagonist. In this study, we used the opposing transcriptional effects driven by LAP and LIP to determine the genuine C/EBPbeta molecular signature in the Hep3B human hepatoma cell line. We subsequently investigated the role of each of the LAP and LIP isoforms in drug-induced Hep3B cell death. METHODS: We engineered Hep3B cells with regulated LAP or LIP expression using the Tet-off expression system. The genes that showed inverse regulation by LAP and LIP were identified by cDNA array analysis. The cohort of direct- C/EBPbeta-targets was distinguished from indirect-targets by ChIP-on-chip analysis. RESULTS: We characterized 676 genes by this approach. Among these genes, 39 are novel direct targets of C/EBPbeta. Eleven of these new direct targets are involved in cell survival, suggesting critical roles for LAP/LIP isoforms in this cellular process. Therefore, we examined the effects of LAP and LIP over-expression on cell survival. We show that LIP promotes survival in staurosporine- or taxol-induced Hep3B cell death. CONCLUSIONS: Our study provides new molecular and cellular insights into the role of C/EBPbeta in cells of hepatic origin.
|
Authors | Gaëlle Saint-Auret, Jean-Louis Danan, Martine Hiron, Céline Blache, Eric Sulpice, Simon Tendil, Maryvonne Daveau, Xavier Gidrol, Jean-Philippe Salier |
Journal | Journal of hepatology
(J Hepatol)
Vol. 54
Issue 6
Pg. 1185-94
(Jun 2011)
ISSN: 1600-0641 [Electronic] Netherlands |
PMID | 21145827
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved. |
Chemical References |
- CCAAT-Enhancer-Binding Protein-beta
- Protein Isoforms
- Staurosporine
- Paclitaxel
|
Topics |
- CCAAT-Enhancer-Binding Protein-beta
(genetics, physiology)
- Carcinoma, Hepatocellular
(genetics, pathology)
- Cell Death
(drug effects, genetics, physiology)
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Cell Survival
(drug effects, genetics, physiology)
- Gene Expression Profiling
- Genetic Engineering
- Humans
- Liver Neoplasms
(genetics, pathology)
- Models, Biological
- Oligonucleotide Array Sequence Analysis
- Paclitaxel
(pharmacology)
- Protein Isoforms
(genetics, physiology)
- Staurosporine
(pharmacology)
- Transcription, Genetic
|